Young Kyung Bae

Young Kyung Bae

Auto-generated profile, based on publicly available information

Young Kyung Bae

Department of Pathology, Yeungnam University College of Medicine, Daegu, Korea

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 January 2006 in Clinical Cancer Research
Verified
Journal Article
Closed access
PDF file
BYBibo Yuan
Bibo Yuan
YXYi Xu
Yi Xu
JWJu-Hyung Woo
Ju-Hyung Woo
YWYunyue Wang
Yunyue Wang
YBYoung Kyung Bae
Young Kyung Bae
EGEdward Gabrielson
Edward Gabrielson
Purpose: Most breast cancers have chromosomal instability that seems related to defective mitotic spindle checkpoints. Because the molecular basis of this defect is unknown, we evaluated breast cancer cell lines and tissues for possible defects involving the major mitotic checkpoint genes responsible for maintaining chromosomal stability.

1 October 2013 in Human Pathology
Verified
Journal Article
Closed access
YBYoung Kyung Bae
Young Kyung Bae
AKAeri Kim
Aeri Kim
MKMin Kyoung Kim
Min Kyoung Kim
JCJung Eun Choi
Jung Eun Choi
SKSu Hwan Kang
Su Hwan Kang
SLSoo Jung Lee
Soo Jung Lee

22 August 2014 in Annals of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
JCJung Eun Choi
Jung Eun Choi
SKSu Hwan Kang
Su Hwan Kang
SLSoo Jung Lee
Soo Jung Lee
YBYoung Kyung Bae
Young Kyung Bae

1 March 2003
Verified
Journal Article
Closed access
DPDale Porter
Dale Porter
JLJaana Lahti-Domenici
Jaana Lahti-Domenici
AKAparna Keshaviah
Aparna Keshaviah
YBYoung Kyung Bae
Young Kyung Bae
PAPedram Argani
Pedram Argani
KPKornelia Polyak
Kornelia Polyak

2 September 2003 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
DPDale Porter
Dale Porter
SWStanislawa Weremowicz
Stanislawa Weremowicz
KCKoei Chin
Koei Chin
PSPankaj Seth
Pankaj Seth
AKAparna Keshaviah
Aparna Keshaviah
KPKornelia Polyak
Kornelia Polyak
Using serial analysis of gene expression (SAGE), we identified a SAGE tag that was present only in invasive breast carcinomas and their lymph node metastases. The transcript corresponding to this SAGE tag, dermcidin (DCD), encodes a secreted protein normally expressed only in the pons of the brain and sweat glands. Array comparative genomic hybridization, fluorescencein situhybridization, and immunohistochemical analyses determined that DCD is overexpressed in ≈10% of invasive breast carcinomas; in some cases its overexpression is coupled with a focal copy number gain of its locus at 12q13.1, and its expression is associated with advanced clinical stage and poor prognosis. Expression of DCD in breast cancer cells promotes cell growth and survival and reduces serum dependency. Putative high- and low-affinity receptors for DCD are present on the cell surface of breast carcinomas and neurons of the brain. Based on these data we hypothesize that DCD may play a role in tumorigenesis by means of enhancing cell growth and survival in a subset of breast carcinomas.

15 September 2004 in Clinical Cancer Research
Verified
Journal Article
Open access
PDF file
YBYoung Kyung Bae
Young Kyung Bae
ABAmy Brown
Amy Brown
EGElizabeth Garrett
Elizabeth Garrett
DBDaniel Bornman
Daniel Bornman
MFMary Jo Fackler
Mary Jo Fackler
EGEdward Gabrielson
Edward Gabrielson
Purpose: A number of different genes are known to be inactivated by aberrant hypermethylation in breast cancer, but it is still unknown to what extent these epigenetic alterations differ according to specific breast cancer phenotypes. We sought to determine whether the extent of hypermethylation or defined profiles of gene hypermethylation are associated with biological characteristics of breast cancers. Experimental Design: We evaluated methylation status of 12 different genes in a series of 109 invasive breast tumors, representing the ductal, lobular, and mucinous histologic subtypes using methylation-specific PCR. Frequencies of methylation were compared across the recognized histologic classes, and multivariate techniques (latent class analysis, factor analysis, recursive partitioning, and hierarchical clustering) were used to seek patterns of methylation for individual genes that distinguish recognized histologic types of breast cancer or define breast cancer phenotypes on a molecular level. Results: All 109 cases studied have aberrant methylation of multiple genes (3 to 10 genes per case), demonstrating that gene hypermethylation is pervasive in breast cancer. Lobular cancers and mucinous cancers, which often have relatively low levels of chromosomal changes, have higher overall frequencies of hypermethylation than ductal cancers (49% in lobular and mucinous versus 40% in ductal), but there is a relatively unimodal distribution of methylation frequency for all three histologic types. Only one of the individual genes studied, BRCA1, has a variable frequency of methylation that is significantly dependent on histologic pattern of tumor growth, with a higher frequency of methylation in mucinous cancers than ductal or lobular cancers. Although some trends of histology-specific gene methylation were seen, methylation patterns could not definitively classify breast cancers according to histologic type. Conclusions: Although a more comprehensive hypermethylation profile could potentially be useful for breast cancer classification and understanding the biology of this disease, it appears that the hypermethylation patterns across various forms of breast cancer are less distinct than those between breast cancer and cancers of different tissue origins. Furthermore, the relatively unimodal distribution of methylation frequency for all three histologic types does not support there being a distinct CpG island methylator phenotype for breast cancer.